Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19

Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. Critical care immunotherapy company CytoSorbents Corp....

The Great Dichotomy

One of the advantages of being a sexagenarian is that after forty years investing in stocks, bonds, commodities, and currencies you have a pretty good idea when something is not exactly "right." If you have lived a good, normal life and you still have decent control of ov...

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...

Barrick Offers to Buy Rest of Project to Resolve Government Dispute

The situation and the gold major's proposal are discussed in a Haywood report. In a May 23 research note, Haywood analyst Kerry Smith reported that Barrick Gold Corp. (ABX:TSX; GOLD:NYSE) proposed to acquire the remaining 36.1% interest in Acacia, taking Barrick ...

Searching for the most promising non-U.S. investment options

When scanning the various investment boards and forums on the Internet these days, it's obvious that most people have very low confidence both in the economy and the government's efforts to fix it. "Smoke and mirrors" is a common theme directed at the officials wh...

How the U.S. government guaranteed the coming food crisis

Over the last several years, I've written constantly on the growing likelihood of a global currency collapse . The governments of Europe and the United States have accumulated debts so large they can't ever hope to repay them, except with currencies whose value will be i...

Canadian mining, oil & gas have a lot to lose from minority government

In mid-August, a ground-breaking ceremony of sorts took place in Edmonton for the Trans Mountain Pipeline project . Natural Resources Minister Amarjeet Sohi picked the yard of pipeline contractor SA Energy to announce that Trans Mountain Corp. is moving forward to constr...

BIGG Digital Assets, Bitcoin Group, Chainalysis - why invest now?

BIGG Digital Assets, Bitcoin Group, Chainalysis - why invest now? The blockchain hype was around two years ago and a lot has changed since then. A consolidation phase has cleared the market and what has remained are the companies and teams that have been able to convin...

Homebuilding stocks are in for a nasty surprise

"You can't believe how screwed up things are down here… " This weekend, I met up with a real estate expert, M, from South Florida. M specializes in REO. REO stands for "Real Estate Owned." Banks lend money to homeowners. Sometimes homeowners don't make their int...
1 2 3 4 5 6 7 8 9 10 ...